Innoxel is an emerging Contract Development and Manufacturing Organization (CDMO) based in Vadodara, India specializing in aseptic as well as terminal sterilized production of injectable vials, pre-filled syringes, and oral liquids.
An integrated pharmaceutical company, Innoxel Lifesciences is equipped with Research & Formulation Development as well as manufacturing capabilities for patented drug-delivery formulations in niche therapies of oncology & critical care.
Focusing on regulated markets such as the USA, we aim to augment India’s rapidly growing global market presence delivering unparalleled quality standards.
Quality Management uses quality assurance and control of process and products to achieve to achieve more consistent quality and is responsible for the below deliverables:
Know MoreWith a team of 150+ finest manufacturing and quality professionals from across the country, we are currently building a portfolio of complex generics including an NDA portfolio comprising long-acting forms of already approved USFDA drugs in therapeutic areas resolving several clearly established key patient compliance and adherence challenges associated with the present standard of care.
Innoxel is committed to reducing its carbon footprint through the deployment and implementation of the best practices in